A pilot study of heat immunotherapy using cationic magnetoliposome for advanced melanoma patients - combined therapy with topical imiquimod immunotherapy - Combination of heat immunotherapy and topical imiquimod immunotherapy for adavanced melanoma patients

Department of Dermatology, Shinshu University School of Medicine0 个研究点目标入组 5 人开始时间: 2011年10月1日最近更新: 2023年10月17日

适应症

试验速览

The trial was terminated.

•1. An anti-ancer therapy has been recieved within previoous 4 weeks 2. Patients who have brain matastases 3. Patients who have a life expectancy of less than 6 months 4. Patients who are pregnant or nursing 5. Patients who have severe pleural or pericardial effusion or ascites 6. Patients who have active infection 7. Patients who have other malignancies 8. Patients who are unable to keep protocol due to psychiatric, familial, social or traffic disadvantage 9. Patients who have metals inside the body near (within 10 cm) the lesion where alternative magnetic field is put 10. Patients who have active asthma, or have had severe anaphilaxis before 11. Patients who are judged inappropriate to be enrolled in this study by clinical investigators

发起方

Department of Dermatology, Shinshu University School of Medicine